戻る Agenda
Session 5: EU Updates
Session Chair(s)
Mick Foy
Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Hans-Georg Eichler, MD, MSc
Consulting Physician
Austrian Association of Social Security Bodies, Austria
Regulations and expectations for pharmacovigilance in the EEA continue to evolve. This session will explore recent developments related to postmarketing pharmacovigilance as well as the practice of drug safety during clinical trials. The focus will be on the evolving situation in the EEA, set in a global context.
Speaker(s)
Speaker
Mick Foy
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Director of Delivery
Speaker
Vicki Edwards, RPh
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
Speaker
Valerie E. Simmons, MD, FFPM
Eli Lilly and Company Ltd, United Kingdom
Senior Medical Fellow, Global Patient Safety